Phenotypic and Molecular Characterization of Multidrug Resistant Staphylococcus Aureus Isolates from Clinical Samples in Diyala, Iraq
Journal of Pioneering Medical Sciences · 05.07.2026 · 15 (6) · 186-192
DOI: 10.47310/jpms2026150624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pioneering Medical Sciences, online erschienen am 05.07.2026. Verfasst von Dalia Abbas Abood Farhan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
A total of 250 clinical specimens (burns, wounds, urine, blood, nasal swabs, middle-ear discharge, throat swabs and sputum were collected from inpatients and outpatients of both sexes and all age groups at Al-Batool Maternity and Children Hospital and Baqubah Teaching Hospital, Diyala Governorate, between November 2024 and March 2025. Eighty isolates were identified as Staphylococcus aureus on the basis of phenotypic, cultural and biochemical characteristics, and identification was confirmed using the VITEK-2-Compact system. Susceptibility to 12 antimicrobial agents was determined by the Kirby-Bauer disc diffusion method, and inhibition zones were interpreted according to current Clinical and Laboratory Standards Institute (CLSI) criteria. The highest resistance was recorded against oxacillin (90%), followed by amoxicillin and ceftriaxone (86.25% each) and ampicillin (78.75%); resistance to erythromycin and azithromycin was 67.5%, to levofloxacin 42.5%, to ciprofloxacin and trimethoprim–sulfamethoxazole 40%, and to amikacin and gentamicin 38.75% and 37.5%, respectively. The lowest resistance was observed against vancomycin (12.5%). Applying the international criteria of Maiorano’s et al. (2012), 61 isolates (76.25%) were classified as multidrug-resistant (MDR), 7 (8.75%) as extensively drug resistant (XDR), and the remaining 12 (15%) as non-MDR. Phenotypic screening showed that all isolates produced β-haemolysis, coagulase and gelatinase (100%), whereas extended-spectrum β-lactamase (ESβL), metalo-β-lactamase (MβL) and class C β-lactamase (AmpC) were detected in 34 (42.5%), 51 (63.75%) and 62 (77.5%) of isolates, respectively. To explore the genetic basis of sulphonamide resistance, the DNA of 16 representative MDR isolates was screened by polymerase chain reaction (PCR); sul1 was detected in 6 isolates (37.5%) and sul2 in 7 isolates (43.75%). Because the molecular analysis was restricted to this purposively selected subset, the genotypic findings should be interpreted as indicative rather than representative of all isolates. Overall, the study documents a high burden of MDR S. aureus in clinical settings in Diyala and provides preliminary evidence linking phenotypic sulphonamide resistance to the carriage of sul1 and sul2, supporting the need for continued antimicrobial surveillance and stewardship.
Zitieren
APA
Farhan, D. A. A., Al-Rajab, I. A. M., & Ali, N. J. A. (2026). Phenotypic and Molecular Characterization of Multidrug Resistant Staphylococcus Aureus Isolates from Clinical Samples in Diyala, Iraq. Journal of Pioneering Medical Sciences, 15(6), 186-192. https://doi.org/10.47310/jpms2026150624
Vancouver
Farhan DAA, Al-Rajab IAM, Ali NJA. Phenotypic and Molecular Characterization of Multidrug Resistant Staphylococcus Aureus Isolates from Clinical Samples in Diyala, Iraq. Journal of Pioneering Medical Sciences. 2026;15(6):186-192. doi:10.47310/jpms2026150624
BibTeX
@article{Farhan2026,
author = {Farhan, Dalia Abbas Abood and Al-Rajab, Ibrahim Adnan Mahmoud and Ali, Noor Jabbar Ahmed},
title = {Phenotypic and Molecular Characterization of Multidrug Resistant Staphylococcus Aureus Isolates from Clinical Samples in Diyala, Iraq},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {6},
pages = {186--192},
doi = {10.47310/jpms2026150624}
}
EUVIMED